274 related articles for article (PubMed ID: 32779242)
1. 17-Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury.
Ma Y; Brown PM; Lin DD; Ma J; Feng D; Belyaeva OV; Podszun MC; Roszik J; Allen JN; Umarova R; Kleiner DE; Kedishvili NY; Gavrilova O; Gao B; Rotman Y
Hepatology; 2021 May; 73(5):1701-1716. PubMed ID: 32779242
[TBL] [Abstract][Full Text] [Related]
2. 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.
Ma Y; Belyaeva OV; Brown PM; Fujita K; Valles K; Karki S; de Boer YS; Koh C; Chen Y; Du X; Handelman SK; Chen V; Speliotes EK; Nestlerode C; Thomas E; Kleiner DE; Zmuda JM; Sanyal AJ; ; Kedishvili NY; Liang TJ; Rotman Y
Hepatology; 2019 Apr; 69(4):1504-1519. PubMed ID: 30415504
[TBL] [Abstract][Full Text] [Related]
3. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
4. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
[TBL] [Abstract][Full Text] [Related]
5. Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease.
Wang M; Li J; Li H; Dong B; Jiang J; Liu N; Tan J; Wang X; Lei L; Li H; Sun H; Tang M; Wang H; Yan H; Li Y; Jiang J; Peng Z
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628360
[TBL] [Abstract][Full Text] [Related]
6. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Lytle KA; Jump DB
PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model.
Ma Y; Cai H; Smith J; Chu CH; Mercer SE; Boehm S; Mcdonald I; Zinker B; Cheng D
J Lipid Res; 2024 Mar; 65(3):100514. PubMed ID: 38309418
[TBL] [Abstract][Full Text] [Related]
8. Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance.
Belmonte FR; Dedousis N; Sipula I; Desai NA; Singhi AD; Chu Y; Zhang Y; Bannwarth S; Paquis-Flucklinger V; Harrington L; Shiva S; Jurczak MJ; O'Doherty RM; Kaufman BA
PLoS One; 2019; 14(5):e0203101. PubMed ID: 31136580
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
10. β-catenin links hepatic metabolic zonation with lipid metabolism and diet-induced obesity in mice.
Behari J; Li H; Liu S; Stefanovic-Racic M; Alonso L; O'Donnell CP; Shiva S; Singamsetty S; Watanabe Y; Singh VP; Liu Q
Am J Pathol; 2014 Dec; 184(12):3284-98. PubMed ID: 25300578
[TBL] [Abstract][Full Text] [Related]
11. Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism.
Buyco DG; Dempsey JL; Scorletti E; Jeon S; Lin C; Harkin J; Bayen S; Furth EE; Martin J; Delima M; Hooks R; Sostre-Colón J; Gharib SA; Titchenell PM; Carr RM
PLoS One; 2023; 18(5):e0281954. PubMed ID: 37134024
[TBL] [Abstract][Full Text] [Related]
12. Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism.
Chen J; Liang B; Bian D; Luo Y; Yang J; Li Z; Zhuang Z; Zang S; Shi J
Biochem Biophys Res Commun; 2019 Oct; 518(4):691-697. PubMed ID: 31472960
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
14. Role of HSD17B13 in the liver physiology and pathophysiology.
Su W; Mao Z; Liu Y; Zhang X; Zhang W; Gustafsson JA; Guan Y
Mol Cell Endocrinol; 2019 Jun; 489():119-125. PubMed ID: 30365983
[TBL] [Abstract][Full Text] [Related]
15. Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
Kim TH; Banini BA; Asumda FZ; Campbell NA; Hu C; Moser CD; Shire AM; Han S; Ma C; Krishnan A; Mounajjed T; White TA; Gores GJ; LeBrasseur NK; Charlton MR; Roberts LR
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G333-G344. PubMed ID: 32683952
[TBL] [Abstract][Full Text] [Related]
16. High-fat diet overfeeding promotes nondetrimental liver steatosis in female mice.
Arisqueta L; Navarro-Imaz H; Labiano I; Rueda Y; Fresnedo O
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G772-G780. PubMed ID: 30095299
[TBL] [Abstract][Full Text] [Related]
17. Pregnane X receptor knockout mitigates weight gain and hepatic metabolic dysregulation in female C57BL/6 J mice on a long-term high-fat diet.
Gebreyesus LH; Choi S; Neequaye P; Mahmoud M; Mahmoud M; Ofosu-Boateng M; Twum E; Nnamani DO; Wang L; Yadak N; Ghosh S; Gonzalez FJ; Gyamfi MA
Biomed Pharmacother; 2024 Apr; 173():116341. PubMed ID: 38428309
[TBL] [Abstract][Full Text] [Related]
18. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysteroid (17β) dehydrogenase 13 deficiency triggers hepatic steatosis and inflammation in mice.
Adam M; Heikelä H; Sobolewski C; Portius D; Mäki-Jouppila J; Mehmood A; Adhikari P; Esposito I; Elo LL; Zhang FP; Ruohonen ST; Strauss L; Foti M; Poutanen M
FASEB J; 2018 Jun; 32(6):3434-3447. PubMed ID: 29401633
[TBL] [Abstract][Full Text] [Related]
20. A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice.
Shankar K; Metzger NP; Lawrence C; Gupta D; Osborne-Lawrence S; Varshney S; Singh O; Richard CP; Zaykov AN; Rolfts R; DuBois BN; Perez-Tilve D; Mani BK; Hammer STG; Zigman JM
Mol Metab; 2024 Jun; 84():101950. PubMed ID: 38697291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
